"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection (CCRPWAR)
Primary Purpose
Rectal Cancer, Anal Canal Cancer
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Traditional Closure
"Cross" closure
Sponsored by
About this trial
This is an interventional treatment trial for Rectal Cancer focused on measuring Traditional closure, "Cross" closure, Rectal cancer, Anal canal cancer, Abdominoperineal resection
Eligibility Criteria
Inclusion Criteria:
- Age: 18-75 years old;
- ECOG performance status: 0-2;
- Histologically confirmed rectal cancer or anal canal cancer;
- Completely resected the primary tumor;
- No evidence of distant metastasis;
- Tolerable general anesthesia;
- Total radiation dose of 45-50 Gy needed if the patient needs to receive routine segmental radiotherapy;
- Provision of written informed consent.
Exclusion Criteria:
- Emergency surgery required when the patients combined with acute ileus, perforation and hemorrhage;
- Extralevator abdominoperineal resection needed;
- American Society of Anesthesiologists (ASA) IV or V;
- Combined with other tumors;
- Severe mental illness;
(7)Serious cardiovascular disease, uncontrolled infections, or other serious uncontrolled concomitant disease; (8)Expectation of lateral lymph node dissection preoperatively
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Traditional Closure
"Cross" Closure
Arm Description
Patients receive primary closure discontinuously for reconstruction of APR perineal wound
Patients receive "cross" closure for reconstruction of APR perineal wound
Outcomes
Primary Outcome Measures
Complication rate of perineal wound
the complications of perineal wound are include wound infection, wound effusion, wound liquefaction, wound dehiscence, seroma or hematoma ,delayed wound healing, presacral or perineal abscess, perineal or pelvic floor hernia
Secondary Outcome Measures
Primary wound healing rate
the Primary wound healing rate within 30 days after operation
CTCAE grade for complications of perineal wound
the CTCAE grade for complications of perineal wound within 30 days after surgery
The incidence of each complication of perineal wound
The incidence of each complication of perineal wound within 30 days after surgery
The rate of reoperation
The rate of reoperation within 30 days after surgery
The volumes of presacral drainage
The volumes of presacral drainage within 3, 5, 7 days after surgery
The volumes of presacral residual cavity hydrops
The volumes of presacral residual cavity hydrops within 3 and 7 days postoperatively
The times of dressing change of perineal wound
The times of dressing change of perineal wound within 3, 5, 7 days after surgery
Removal time of presacral drainage tube
Removal time of presacral drainage tube within 30 days after surgery
Scar scores for perineal wound and evaluation of patients' overall satisfaction
Scar scores for perineal wound and evaluation of patients' overall satisfaction within 30 days after surgery
Hospital stay after surgery
Hospital stay after surgery within 30 days after surgery
The operation time
The operation time
Full Information
NCT ID
NCT03731754
First Posted
October 26, 2018
Last Updated
November 7, 2018
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Collaborators
First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Jinan University, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Southern Medical University, China, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou First People's Hospital, Affiliated Hospital of Guangdong Medical University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Meizhou People's Hospital, Jieyang People's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03731754
Brief Title
"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
Acronym
CCRPWAR
Official Title
"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection in Rectal and Anal Cancer Patients: a Multi-center, Randomized, Open-Label, Positive, Parallel Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 20, 2018 (Anticipated)
Primary Completion Date
November 20, 2020 (Anticipated)
Study Completion Date
December 20, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Collaborators
First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Jinan University, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Southern Medical University, China, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou First People's Hospital, Affiliated Hospital of Guangdong Medical University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Meizhou People's Hospital, Jieyang People's Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
How to reduce the complications of perineal wound after abdominoperineal resection (APR) has always been a hot topic in the medical field.To reduce the complications of perineal wound and the primary healing of perineal wound must meet the two principles of "unobstructed drainage" and " reduced tension closure".This concept is similar to the concepts of closure of enterostomy in rectal cancer patients. It was reported that use of cross-stitch closure can significantly reduce complications of closure of enterostomy. So the investigator ever used the "cross" closure to reconstruct the perineal wound of APR, which was really decrease the complications of perineal wound. However, more clinical trails was needed to confirm the conclusion.
Detailed Description
Perineal wound problems after abdominoperineal resection (APR) for rectal cancer is reported in up to 25%~66% of patients,if the perineum does not heal primarily, the secondary wound healing may prolong hospital stay, may necessitate surgical reintervention, and often requires intensive wound care for several months. Great efforts have been taken to reduce the complications of perineal wound of APR, but the incidence of the perineal wound complications are not effectively decreased.
It was reported that one of the most important factors to determine the primary healing of perineal wound is whether the anterior sacral drainage and perineal stump drainage are sufficient and effective or not, which is similar to the concept of closure of enterostomy.
Previously, it was reported that "cross" closure is an effective method of skin closure for stoma reversal, which allows increased surgical exposure, reduces suture, smooth drainage, aesthetic healing simplifies wound care, and gives a neat cosmetic result.
Therefore, because of the success use of "cross" closure in stoma reversal to reduce the complications of perineal wound, the investigator used the "cross" closure to reconstruct the perineal wound of APR, and it really can decrease the complications of perineal wound. However, more clinical trails are needed to confirm the conclusion.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer, Anal Canal Cancer
Keywords
Traditional closure, "Cross" closure, Rectal cancer, Anal canal cancer, Abdominoperineal resection
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
346 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Traditional Closure
Arm Type
Active Comparator
Arm Description
Patients receive primary closure discontinuously for reconstruction of APR perineal wound
Arm Title
"Cross" Closure
Arm Type
Experimental
Arm Description
Patients receive "cross" closure for reconstruction of APR perineal wound
Intervention Type
Procedure
Intervention Name(s)
Traditional Closure
Intervention Description
Primary closure discontinuously the perineal wound of APR
Intervention Type
Procedure
Intervention Name(s)
"Cross" closure
Intervention Description
Two triangles of skin in the horizontal direction are excised to enlarge the skin incision, and the tumor resected. Then circumferential subcuticular suture of wound, and with tightening of the circumferential suture, the wound resembles a cross.
Primary Outcome Measure Information:
Title
Complication rate of perineal wound
Description
the complications of perineal wound are include wound infection, wound effusion, wound liquefaction, wound dehiscence, seroma or hematoma ,delayed wound healing, presacral or perineal abscess, perineal or pelvic floor hernia
Time Frame
Within 30 days after operation
Secondary Outcome Measure Information:
Title
Primary wound healing rate
Description
the Primary wound healing rate within 30 days after operation
Time Frame
Within 30 days after operation
Title
CTCAE grade for complications of perineal wound
Description
the CTCAE grade for complications of perineal wound within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
The incidence of each complication of perineal wound
Description
The incidence of each complication of perineal wound within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
The rate of reoperation
Description
The rate of reoperation within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
The volumes of presacral drainage
Description
The volumes of presacral drainage within 3, 5, 7 days after surgery
Time Frame
Within 3, 5, 7 days after surgery
Title
The volumes of presacral residual cavity hydrops
Description
The volumes of presacral residual cavity hydrops within 3 and 7 days postoperatively
Time Frame
3 and 7 days postoperatively
Title
The times of dressing change of perineal wound
Description
The times of dressing change of perineal wound within 3, 5, 7 days after surgery
Time Frame
Within 3, 5, 7 days after surgery
Title
Removal time of presacral drainage tube
Description
Removal time of presacral drainage tube within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
Scar scores for perineal wound and evaluation of patients' overall satisfaction
Description
Scar scores for perineal wound and evaluation of patients' overall satisfaction within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
Hospital stay after surgery
Description
Hospital stay after surgery within 30 days after surgery
Time Frame
Within 30 days after surgery
Title
The operation time
Description
The operation time
Time Frame
Intraoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age: 18-75 years old;
ECOG performance status: 0-2;
Histologically confirmed rectal cancer or anal canal cancer;
Completely resected the primary tumor;
No evidence of distant metastasis;
Tolerable general anesthesia;
Total radiation dose of 45-50 Gy needed if the patient needs to receive routine segmental radiotherapy;
Provision of written informed consent.
Exclusion Criteria:
Emergency surgery required when the patients combined with acute ileus, perforation and hemorrhage;
Extralevator abdominoperineal resection needed;
American Society of Anesthesiologists (ASA) IV or V;
Combined with other tumors;
Severe mental illness;
(7)Serious cardiovascular disease, uncontrolled infections, or other serious uncontrolled concomitant disease; (8)Expectation of lateral lymph node dissection preoperatively
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lei Wang, MD, PhD
Phone
86-20-38254052
Email
leiwangyinhu@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lei Wang, MD, PhD
Organizational Affiliation
Sixth Affiliated Hospital, Sun Yat-sen University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
We'll reach out to this number within 24 hrs